The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fambrough Douglas since 2014.
This trader's CIK number is 1259856.
At the time of last reporting, Fambrough Douglas was the Chief Executive Officer of Dicerna Pharmaceuticals Inc. (stock ticker symbol DRNA).
Also see all insider trading activities at Dicerna Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | DRNA | 5,000 | $110,480 | 0 | $0 | 213,565 | $574,668 |
| 2020 | DRNA | 10,000 | $180,600 | 0 | $0 | 0 | $0 |
| 2019 | DRNA | 0 | $0 | 139,021 | $3,683,238 | 80,000 | $273,600 |
| 2016 | DRNA | 33,100 | $122,643 | 0 | $0 | 0 | $0 |
| 2014 | DRNA | 5,000 | $75,000 | 0 | $0 | 11,800 | $40,356 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-15 | DRNA | Option Ex | 13,750 | .00 | 0 |
| 2021-12-10 | DRNA | Option Ex | 179,865 | 3.19 | 574,668 |
| 2021-08-10 | DRNA | Buy | 5,000 | 22.10 | 110,480 |
| 2021-01-08 | DRNA | Option Ex | 19,950 | .00 | 0 |
| 2020-09-01 | DRNA | Buy | 10,000 | 18.06 | 180,600 |
| 2019-12-18 | DRNA | Option Ex | 80,000 | 3.42 | 273,600 |
| 2019-12-17 | DRNA | Sale | 59,021 | 26.54 | 1,566,358 |
| 2019-12-18 | DRNA | Sale | 80,000 | 26.46 | 2,116,880 |
| 2016-11-14 | DRNA | Buy | 16,600 | 3.78 | 62,748 |
| 2016-11-15 | DRNA | Buy | 16,500 | 3.63 | 59,895 |
| 2014-12-17 | DRNA | Option Ex | 2,500 | 3.42 | 8,550 |
| 2014-01-29 | DRNA | Buy | 5,000 | 15.00 | 75,000 |
| 2013-11-11 | DRNA | Option Ex | 9,300 | 3.42 | 31,806 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fambrough Douglas (Chief Executive Officer of Dicerna Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.